Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637878 · ClinicalTrials.gov registry record · NA
SCT02 Clinical Accuracy Validation
A NA study, sponsored by Withings.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT06637878: Completed NA study, sponsored by Withings.
NCT06637878 is a NA study that has completed, run by Withings. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06637878, a NA study, has completed, sponsored by Withings.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
The aim of the study is to validate the accuracy of the temporal thermometer of Withings SCT02
Primary Outcome
Mean of the per-subject differences (Investigational - Reference), computed using the first measurement obtained from each subject with each device. A bias closer to 0 °F indicates closer agreement between devices; the sign indicates direction (a negative value means the investigational device read lower, on average, than the reference).
Interventions
- DEVICE Investigational Device (Withings SCT02) temporal thermometer measurement
- DEVICE Reference Device (Withings SCT01) temperature measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2025-01-08 |
| Phase | NA |
What the finished NCT06637878 record still lists
NCT06637878 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Investigational Device (Withings SCT02) temporal thermometer measurement is the first listed.
NCT06637878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06637878 about?
NCT06637878 is a clinical study titled "SCT02 Clinical Accuracy Validation". The aim of the study is to validate the accuracy of the temporal thermometer of Withings SCT02
What is the current status of trial NCT06637878?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2024-10-03. Estimated completion is 2025-01-08.
What interventions are being tested in trial NCT06637878?
The interventions under investigation include: Investigational Device (Withings SCT02) temporal thermometer measurement (DEVICE), Reference Device (Withings SCT01) temperature measurement (DEVICE).
Who is sponsoring clinical trial NCT06637878?
This trial is sponsored by Withings, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06637878's enrollment target sits among peer trials
118 803rd of 2000 higher than 1,194 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI